SCHIFF ANDREW N

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$5M
Insider Sells Quantity
12
Insider Sells Sum
$3.65M

Insider Activity of SCHIFF ANDREW N

The largest purchase of all time was on 2017-08-16 and amounted to 217202 shares of Aclaris Therapeutics, Inc. for $5M.

The largest sale of all time was on 2022-11-11 and amounted to 41160 shares of Aclaris Therapeutics, Inc. for $702,177.

Biography of SCHIFF ANDREW N

No biography is available at this moment.

2022-11-14SaleAclaris Therapeutics, Inc.
ACRS
director
1,371
0.002%
$17.08$23,417-47.65%
2022-11-11SaleAclaris Therapeutics, Inc.
ACRS
director
41,160
0.062%
$17.06$702,177-46.2%
2022-11-10SaleAclaris Therapeutics, Inc.
ACRS
director
11,395
0.0172%
$17.02$193,995-46.05%
2022-10-26SaleAclaris Therapeutics, Inc.
ACRS
director
14,540
0.0225%
$17.00$247,253-42.69%
2022-10-25SaleAclaris Therapeutics, Inc.
ACRS
director
12,018
0.0186%
$17.02$204,516-42.58%
2022-10-24SaleAclaris Therapeutics, Inc.
ACRS
director
14,616
0.0221%
$17.01$248,586-43.63%
2022-10-18SaleAclaris Therapeutics, Inc.
ACRS
director
32,093
0.0478%
$16.89$542,022-42.32%
2022-10-17SaleAclaris Therapeutics, Inc.
ACRS
director
19,944
0.0298%
$16.05$320,087-39.07%
2022-10-07SaleAclaris Therapeutics, Inc.
ACRS
director
7,324
0.0112%
$16.16$118,349-37.61%
2022-10-06SaleAclaris Therapeutics, Inc.
ACRS
director
37,839
0.0562%
$16.54$625,744-40.84%
2022-10-04SaleAclaris Therapeutics, Inc.
ACRS
director
7,700
0.0115%
$16.01$123,259
2022-06-17SaleAclaris Therapeutics, Inc.
ACRS
19,565
0.0288%
$15.14$296,269-3.33%
2017-08-16PurchaseAclaris Therapeutics, Inc.
ACRS
director
217,202
0.6521%
$23.02$5M-22.79%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.